These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 7219685)

  • 1. Blink rates and receptor supersensitivity.
    Karson CN; Staub RA; Kleinman JE; Wyatt RJ
    Neuropharmacology; 1981 Jan; 20(1):91-3. PubMed ID: 7219685
    [No Abstract]   [Full Text] [Related]  

  • 2. MPTP lesions and dopaminergic drugs alter eye blink rate in African green monkeys.
    Lawrence MS; Redmond DE
    Pharmacol Biochem Behav; 1991 Apr; 38(4):869-74. PubMed ID: 1678527
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Estradiol can suppress haloperidol-induced supersensitivity in dyskinetic monkeys.
    Bédard PJ; Boucher R
    Neurosci Lett; 1986 Feb; 64(2):206-10. PubMed ID: 3960400
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Drug effect on blink rates in rhesus monkeys: preliminary studies.
    Karson CN; Staub RA; Kleinman JE; Wyatt RJ
    Biol Psychiatry; 1981 Mar; 16(3):249-54. PubMed ID: 7225488
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The supersensitivity of dopaminergic neurons to apomorphine in rats following chronic haloperidol.
    Vogelsang GD; Piercey MF
    Eur J Pharmacol; 1985 Apr; 110(2):267-9. PubMed ID: 3987817
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lithium effects on haloperidol-induced pre- and postsynaptic dopamine receptor supersensitivity.
    Verimer T; Goodale DB; Long JP; Flynn JR
    J Pharm Pharmacol; 1980 Sep; 32(9):665-6. PubMed ID: 6107377
    [No Abstract]   [Full Text] [Related]  

  • 7. A new animal model of dopamine supersensitivity using s.c. implantation of haloperidol releasing polymers.
    Köhler U; Schröder H; Augustin W; Sabel BA
    Neurosci Lett; 1994 Mar; 170(1):99-102. PubMed ID: 8041522
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Presynaptic dopamine receptors in striatal nerve endings: absence of haloperidol-induced supersensitivity.
    Raiteri M; Cerrito F; Casazza G; Levi G
    Adv Biochem Psychopharmacol; 1980; 24():37-43. PubMed ID: 7405669
    [No Abstract]   [Full Text] [Related]  

  • 9. Presynaptic dopamine receptors: insensitivity to kainic acid and the development of supersensitivity following chronic haloperidol.
    Bannon MJ; Bunney EB; Zigun JR; Skirboll LR; Roth RH
    Naunyn Schmiedebergs Arch Pharmacol; 1980 Jun; 312(2):161-5. PubMed ID: 6772975
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dopamine synthesis: tolerance to haloperidol and supersensitivity to apomorphine depend on presynaptic receptors.
    Biggio G; Casu M; Klimek V; Gessa GL
    Adv Biochem Psychopharmacol; 1980; 24():17-22. PubMed ID: 6996441
    [No Abstract]   [Full Text] [Related]  

  • 11. Long-term effects of early social isolation in Macaca mulatta: changes in dopamine receptor function following apomorphine challenge.
    Lewis MH; Gluck JP; Beauchamp AJ; Keresztury MF; Mailman RB
    Brain Res; 1990 Apr; 513(1):67-73. PubMed ID: 1693540
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The effect of apomorphine on blink kinematics in subhuman primates with and without facial nerve palsy.
    Baker RS; Radmanesh SM; Abell KM
    Invest Ophthalmol Vis Sci; 2002 Sep; 43(9):2933-8. PubMed ID: 12202512
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The effect of dopamine receptor agonist treatment on haloperidol-induced supersensitivity in mice.
    Fayle P; Jackson DM; Jenkins OF; Lafferty PA
    Pharmacol Biochem Behav; 1985 Nov; 23(5):715-20. PubMed ID: 4080755
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Long-term treatment with lithium prevents the development of dopamine receptor supersensitivity.
    Pert A; Rosenblatt JE; Sivit C; Pert CB; Bunney WE
    Science; 1978 Jul; 201(4351):171-3. PubMed ID: 566468
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Chronic ascorbate potentiates the effects of chronic haloperidol on behavioral supersensitivity but not D2 dopamine receptor binding.
    Pierce RC; Rowlett JK; Bardo MT; Rebec GV
    Neuroscience; 1991; 45(2):373-8. PubMed ID: 1762684
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Behavioral pharmacologic studies in the monkey with DD-3480.
    Shibuya T; Nishimori T; Matsuda H; Chen PC
    Int J Clin Pharmacol Ther Toxicol; 1982 Jun; 20(6):251-4. PubMed ID: 6125481
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The effects of chronic lithium on behavioral and biochemical indices of dopamine receptor supersensitivity in the rat.
    Pittman KJ; Jakubovic A; Fibiger HC
    Psychopharmacology (Berl); 1984; 82(4):371-7. PubMed ID: 6427831
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of haloperidol and apomorphine treatment on dopamine receptors in pituitary and striatum.
    Friend WC; Brown GM; Jawahir G; Lee T; Seeman P
    Am J Psychiatry; 1978 Jul; 135(7):839-41. PubMed ID: 665797
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dopaminergic supersensitivity in striatum and olfactory tubercle following chronic administration of haloperidol or clozapine.
    Gianutsos G; Moore KE
    Life Sci; 1977 May; 20(9):1585-91. PubMed ID: 875633
    [No Abstract]   [Full Text] [Related]  

  • 20. [Effect of repeated haloperidol and apomorphine administration on the development of tolerance for catalepsy and dopamine receptor hypersensitivity in mice].
    Zharkovskiĭ AM; Matvienko OA; Nurk AM
    Biull Eksp Biol Med; 1984 Oct; 98(10):444-6. PubMed ID: 6541951
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.